Results
|
1361.
|
Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors. [electronic resource] by
- Xia, Wenle
- Liu, Zuguo
- Zong, Rongrong
- Liu, Leihua
- Zhao, Sumin
- Bacus, Sarah S
- Mao, Yubin
- He, Jia
- Wulfkuhle, Julia D
- Petricoin, Emanuel F
- Osada, Takuya
- Yang, Xiao-Yi
- Hartman, Zachary C
- Clay, Timothy M
- Blackwell, Kimberly L
- Lyerly, Herbert K
- Spector, Neil L
Producer: 20111219
In:
Molecular cancer therapeutics vol. 10
Availability: No items available.
|
|
1362.
|
|
|
1363.
|
|
|
1364.
|
|
|
1365.
|
|
|
1366.
|
Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma. [electronic resource] by
- De Silva, Nadeera
- Schulz, Laura
- Paterson, Anna
- Qain, Wendi
- Secrier, Maria
- Godfrey, Edmund
- Cheow, Heok
- O'Donovan, Maria
- Lao-Sirieix, Pierre
- Jobanputra, Minesh
- Hochhauser, Daniel
- Fitzgerald, Rebecca
- Ford, Hugo
Producer: 20160205
In:
British journal of cancer vol. 113
Availability: No items available.
|
|
1367.
|
|
|
1368.
|
Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells. [electronic resource] by
- Liu, Chun-Yu
- Hu, Ming-Hung
- Hsu, Chia-Jung
- Huang, Chun-Teng
- Wang, Duen-Shian
- Tsai, Wen-Chun
- Chen, Yi-Ting
- Lee, Chia-Han
- Chu, Pei-Yi
- Hsu, Chia-Chi
- Chen, Ming-Huang
- Shiau, Chung-Wai
- Tseng, Ling-Ming
- Chen, Kuen-Feng
Producer: 20161230
In:
Oncotarget vol. 7
Availability: No items available.
|
|
1369.
|
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer. [electronic resource] by
- Guerin, Mathilde
- Rezai, Keyvan
- Isambert, Nicolas
- Campone, Mario
- Autret, Aurélie
- Pakradouni, Jihane
- Provansal, Magali
- Camerlo, Jacques
- Sabatier, Renaud
- Bertucci, François
- Charafe-Jauffret, Emmanuelle
- Hervieu, Alice
- Extra, Jean-Marc
- Viens, Patrice
- Lokiec, François
- Boher, Jean-Marie
- Gonçalves, Anthony
Producer: 20171121
In:
European journal of cancer (Oxford, England : 1990) vol. 86
Availability: No items available.
|
|
1370.
|
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers. [electronic resource] by
- Sun, Bowen
- Mason, Seth
- Wilson, Robert C
- Hazard, Starr E
- Wang, Yubao
- Fang, Rong
- Wang, Qiwei
- Yeh, Elizabeth S
- Yang, Meixiang
- Roberts, Thomas M
- Zhao, Jean J
- Wang, Qi
Producer: 20200420
In:
Oncogene vol. 39
Availability: No items available.
|
|
1371.
|
Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors. [electronic resource] by
- Galsky, Matthew D
- Von Hoff, Daniel D
- Neubauer, Marcus
- Anderson, Thomas
- Fleming, Mark
- Nagarwala, Yasir
- Mahoney, Janine M
- Midwinter, Dawn
- Vocila, Linda
- Zaks, Tal Z
Producer: 20120611
In:
Investigational new drugs vol. 30
Availability: No items available.
|
|
1372.
|
Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235. [electronic resource] by
- Eichhorn, Pieter J A
- Gili, Magüi
- Scaltriti, Maurizio
- Serra, Violeta
- Guzman, Marta
- Nijkamp, Wouter
- Beijersbergen, Roderick L
- Valero, Vanesa
- Seoane, Joan
- Bernards, René
- Baselga, José
Producer: 20081210
In:
Cancer research vol. 68
Availability: No items available.
|
|
1373.
|
|
|
1374.
|
|
|
1375.
|
|
|
1376.
|
|
|
1377.
|
Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: analysis from the NeoALTTO trial. [electronic resource] by
- Azim, Hatem A
- Agbor-Tarh, Dominique
- Bradbury, Ian
- Dinh, Phuong
- Baselga, Jose
- Di Cosimo, Serena
- Greger, James G
- Smith, Ian
- Jackisch, Christian
- Kim, Sung-Bae
- Aktas, Bahriye
- Huang, Chiun-Sheng
- Vuylsteke, Peter
- Hsieh, Ruey Kuen
- Dreosti, Lydia
- Eidtmann, Holger
- Piccart, Martine
- de Azambuja, Evandro
Producer: 20140224
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31
Availability: No items available.
|
|
1378.
|
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy. [electronic resource] by
- Giuliano, Mario
- Hu, Huizhong
- Wang, Yen-Chao
- Fu, Xiaoyong
- Nardone, Agostina
- Herrera, Sabrina
- Mao, Sufeng
- Contreras, Alejandro
- Gutierrez, Carolina
- Wang, Tao
- Hilsenbeck, Susan G
- De Angelis, Carmine
- Wang, Nicholas J
- Heiser, Laura M
- Gray, Joe W
- Lopez-Tarruella, Sara
- Pavlick, Anne C
- Trivedi, Meghana V
- Chamness, Gary C
- Chang, Jenny C
- Osborne, C Kent
- Rimawi, Mothaffar F
- Schiff, Rachel
Producer: 20160607
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21
Availability: No items available.
|
|
1379.
|
|
|
1380.
|
CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer. [electronic resource] by
- Pivot, Xavier
- Manikhas, Alexey
- Żurawski, Bogdan
- Chmielowska, Ewa
- Karaszewska, Boguslawa
- Allerton, Rozenn
- Chan, Stephen
- Fabi, Alessandra
- Bidoli, Paolo
- Gori, Stefania
- Ciruelos, Eva
- Dank, Magdolna
- Hornyak, Lajos
- Margolin, Sara
- Nusch, Arnd
- Parikh, Roma
- Nagi, Fareha
- DeSilvio, Michelle
- Santillana, Sergio
- Swaby, Ramona F
- Semiglazov, Vladimir
Producer: 20150720
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 33
Availability: No items available.
|